Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Xuemei Huang
Pennsylvania State Univ Hershey Med Ctr, Department: Neurology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Penn State Research Foundation
Other : Intellectual property rights (e.g., royalties, patents, copyrights)
Dr. Huang holds intellectual property rights associated with a patent application, filed in May 2018. The invention might become a product used for diagnosis, differential diagnosis, and progression monitoring of Parkinson’s disease.
Although the Intellectual Property rights are held with Penn State Research Foundation (associated with the awardee institution), Penn State University policy does not exclude Penn State-owned intellectual property from the definition of Significant Financial Interest. Additionally, although there has been no revenue from the intellectual property, our institution reviews any intellectual property rights, regardless of value, if related to human subjects research.
Multimodal MRI markers of nigrostriatal pathology in Parkinson's disease
The lack of in vivo biomarker(s) reflecting Parkinson's disease (PD)-related cell loss and associated pathoetiological/physiological processes in nigrostriatal structures has hindered discovery research and limited the ability to evaluate disease-modifying therapies. Recent research has generated excitement for using DTI and R2* MRI measures as biomarker(s) for PD-related pathology in nigrostriatal pathways, but they fall short by the lack of understanding of their clinical implications and biological/pathological underpinnings. Working closely with the NINDS Parkinson's Disease Biomarkers Program (PDBP), the proposed work will investigate multimodal MRI techniques in combination with fluid-based iron (Fe) protein profiles to serve as in vivo markers for PD-related nigrostriatal pathology that can be used as biomarkers for diagnosing PD, following its progression, and gaining mechanistic understanding of PD pathoetiology and pathophysiology.
Filed on October 19, 2018.
Tell us what you know about Xuemei Huang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Xuemei Huang filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Xuemei Huang | Pennsylvania State Univ Hershey Med Ctr | Conflict of Interest | Penn State Research Foundation | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.